» Articles » PMID: 28448993

The Long Non-Coding RNA XIST Controls Non-Small Cell Lung Cancer Proliferation and Invasion by Modulating MiR-186-5p

Overview
Date 2017 Apr 28
PMID 28448993
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Long non-coding RNAs (lncRNAs) are key players in the development and progression of human cancers. The lncRNA XIST (X-inactive specific transcript) has been shown to be upregulated in human non-small cell lung cancer (NSCLC); however, its role and molecular mechanisms in NSCLC cell progression remain unclear.

Methods: qRT-PCR was conducted to assess the expression of XIST and miR-186. Cell proliferation was detected using MTT assay. Cell invasion and migration were evaluated using transwell assay. Cell cycle distribution and apoptosis rates were analyzed by flow cytometry. Luciferase reporter assay was used to identify the direct regulation of XIST and miR-186. A RNA immunoprecipitation was used to analyze whether XIST was associated with the RNA-induced silencing complex (RISC).

Results: We confirmed that XIST was upregulated in NSCLC cell lines and tissues. Functionally, XIST knockdown inhibited cancer cell proliferation and invasion, and induced apoptosis in vitro, and suppressed subcutaneous tumor growth in vivo. Mechanistic investigations revealed a reciprocal repressive interaction between XIST and miR-186-5p. Furthermore, we showed that miR-186-5p has a binding site for XIST. Our data also indicated that XIST and miR-186-5p are likely in the same RNA induced silencing complex.

Conclusion: Together, our data revealed that XIST knockdown confers suppressive function in NSCLC and XIST may be a novel therapeutic marker in this disease.

Citing Articles

Comprehensive insights and In silico analysis into the emerging role of LincRNAs in lung diseases pathogenesis; a step toward ncRNA precision.

Hamdy N, Zaki M, Abdelmaksoud N, Elshaer S, Abd-Elmawla M, Rizk N Funct Integr Genomics. 2025; 25(1):34.

PMID: 39912974 PMC: 11802690. DOI: 10.1007/s10142-025-01540-1.


The regulatory role and therapeutic potential of long non-coding RNA in non-small cell lung cancer.

Xia S, Lu X, Wang W, Pan X, Cui J, Wang S J Cancer. 2025; 16(4):1137-1148.

PMID: 39895777 PMC: 11786035. DOI: 10.7150/jca.103182.


Decoding LncRNA in COPD: Unveiling Prognostic and Diagnostic Power and Their Driving Role in Lung Cancer Progression.

Sweef O, Mahfouz R, Tascioglu T, Albowaidey A, Abdelmonem M, Asfar M Int J Mol Sci. 2024; 25(16).

PMID: 39201688 PMC: 11354875. DOI: 10.3390/ijms25169001.


YY1/circCTNNB1/miR-186-5p/YY1 positive loop aggravates lung cancer progression through the Wnt pathway.

Shen Y, Yang Y, Zhao Y, Nuerlan S, Zhan Y, Liu C Epigenetics. 2024; 19(1):2369006.

PMID: 38913848 PMC: 11197906. DOI: 10.1080/15592294.2024.2369006.


Sufentanil Suppresses Cell Carcinogenesis Via Targeting miR-186-5p/HMGB1 Axis and Wnt/β-Catenin Pathway in Non-Small-Cell Lung Cancer.

Liu D, Huang Y, Shang Y Mol Biotechnol. 2024; 67(3):1054-1064.

PMID: 38470557 DOI: 10.1007/s12033-024-01104-x.